Evidence map›Paper›PMID 37501185›Full record

ArticleOrphanet journal of rare diseases2023

European Achondroplasia Forum guiding principles for the detection and management of foramen magnum stenosis.

Melita Irving, Moeenaldeen AlSayed, Paul Arundel, Geneviève Baujat, Tawfeg Ben-Omran, Silvio Boero, Valérie Cormier-Daire, Svein Fredwall, Encarna Guillen-Navarro, Heike Hoyer-Kuhn and 6 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Review
  4. Foramen magnum decompression in infants and children with achondroplasia: clinical outcomes from a 15-patient surgical series.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 10 countries.

Melita IrvingDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK. Melita.Irving@gstt.nhs.uk.ORCID 0000-0002-2997-4461
Moeenaldeen AlSayedDepartment of Medical Genomics, King Faisal Specialist Hospital and Research Center and Faculty of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
Paul ArundelDepartment of Metabolic Bone Disease, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Geneviève BaujatCentre of Reference for Constitutional Bone Diseases (MOC), Department of Clinical Genetics, Paris Centre University, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.
Tawfeg Ben-OmranDivision of Genetics and Genomic Medicine, Sidra Medicine & Hamad Medical Corporation, Doha, Qatar.
Silvio BoeroPediatric Orthopaedic and Traumatology Unit, Istituto Giannina Gaslini, Genoa, Italy.
Valérie Cormier-DaireCentre of Reference for Constitutional Bone Diseases (MOC), Department of Clinical Genetics, Paris Centre University, INSERM UMR 1163, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.
Svein FredwallTRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Nesodden, Norway.
Encarna Guillen-NavarroMedical Genetics Section, Department of Pediatrics, Virgen de la Arrixaca University Clinical Hospital, IMIB-Pascual Parrilla, University of Murcia-UMU, Murcia; CIBERER-ISCIII, Madrid, Spain.
Heike Hoyer-KuhnChildren's Hospital, University Cologne, Cologne, Germany.
Philip KunkelDepartment of Neurosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Christian LampeClinic of Neuropediatrics, Epileptology and Social Pediatrics, University Hospital Giessen and Marburg, Giessen, Germany.
Mohamad MaghnieDepartment of Pediatrics, IRCCS Istituto Giannina Gaslini, Genova, 16147, Italy.
Klaus MohnikeCentral German Competence Network for Rare Diseases (ZSE), Universitätskinderklinik, Otto-von-Guericke Universität, Magdeburg, Germany.
Geert MortierDepartment of Medical Genetics and Centre for Rare Diseases, Centre of Human Genetics, KU Leuven, Leuven, Belgium.
Sérgio B SousaMedical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra; and University Clinic of Genetics, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal.
Istituto Giannina Gaslini · ITAlfaisal University · SAGuy's and St Thomas' NHS Foundation Trust · GBHamad Medical Corporation · QAHeidelberg University · DEHospitais da Universidade de Coimbra · PTInserm · FRInstitut des Maladies Génétiques Imagine · FRInstituto de Salud Carlos III · ESKU Leuven · BESheffield Children's NHS Foundation Trust · GBSunnaas sykehus · NOUniversitätskinderklinik · DEUniversitätsklinikum Gießen und Marburg · DEUniversity Hospital Cologne · DE

Funding

Medical Research Council MR/W01761X/1
6 · The paper itself

Abstract

Foramen magnum stenosis is a serious, and potentially life-threatening complication of achondroplasia. The foramen magnum is smaller in infants with achondroplasia, compared with the general population, and both restricted growth in the first 2 years and premature closure of skull plate synchondroses can contribute to narrowing. Narrowing of the foramen magnum can lead to compression of the brainstem and spinal cord, and result in sleep apnoea and sudden death. There is a lack of clarity in the literature on the timing of regular monitoring for foramen magnum stenosis, which assessments should be carried out and when regular screening should be ceased. The European Achondroplasia Forum (EAF) is a group of clinicians and patient advocates, representative of the achondroplasia community. Members of the EAF Steering Committee were invited to submit suggestions for guiding principles for the detection and management of foramen magnum stenosis, which were collated and discussed at an open workshop. Each principle was scrutinised for content and wording, and anonymous voting held to pass the principle and vote on the level of agreement. A total of six guiding principles were developed which incorporate routine clinical monitoring of infants and young children, timing of routine MRI screening, referral of suspected foramen magnum stenosis to a neurosurgeon, the combination of assessments to inform the decision to decompress the foramen magnum, joint decision making to proceed with decompression, and management of older children in whom previously undetected foramen magnum stenosis is identified. All principles achieved the ≥ 75% majority needed to pass (range 89-100%), with high levels of agreement (range 7.6-8.9). By developing guiding principles for the detection and management of foramen magnum stenosis, the EAF aim to enable infants and young children to receive optimal monitoring for this potentially life-threatening complication.

Indexed as

AchondroplasiaBone DiseasesSleep Apnea SyndromesAdolescentChildChild, PreschoolConstriction, PathologicForamen MagnumHumansInfantSpinal CordAchondroplasiaDetectionEuropean Achondroplasia ForumForamen Magnum StenosisGuiding principlesManagementRecommendations

Identifiers

PMID37501185
PMCPMC10375694
OpenAlexW4385330730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.